Showing 9941-9950 of 15035 results for "reverse type I diabetes".
- Breathing Rhythms Linked to Memory Consolidation During Sleep, Study Findshttps://reachmd.com/news/breathing-rhythms-linked-to-memory-consolidation-during-sleep-study-finds/2470683/A groundbreaking study has revealed that breathing plays a central role in synchronizing brain waves in the hippocampus during sleep, a discovery that deepens our understanding of how memories are strengthened overnight. Northwestern Medicine researchers have identified, for the first time, that
- Targeting Brain Enzymes to Combat Obesity: A New Frontier in Weight Controlhttps://reachmd.com/news/targeting-brain-enzymes-to-combat-obesity-a-new-frontier-in-weight-control/2470674/The fight against obesity has taken a step forward with new research highlighting how the brain’s endocannabinoid system influences food intake and physical activity. A team of researchers at the Université de Montréal’s CRCHUM has discovered that modulating a specific brain enzyme could help cur
- Study Explores How Moderate to Severe Hand Eczema Affects Quality of Lifehttps://reachmd.com/news/moderate-severe-hand-eczema-quality-life-challenges-explored/2470762/Even mild hand eczema can significantly impair one's quality of life and mental health, according to a new study. The findings, presented at the recent Revolutionizing Atopic Dermatitis (RAD) Conference, spanned data collected from 2013 to 2020, addressed the outsized impact of hand eczem
- Nasal Antibody Testing May Predict COVID-19 Severity, Study Findshttps://reachmd.com/news/nasal-antibody-testing-may-predict-covid-19-severity-study-finds/2470757/As the United States prepares for its fifth winter of COVID-19, a recent study from Emory University has identified a key antibody in the nasal passages that could help predict the severity of the disease. Researchers found that patients with a specific antibody, called anti-interferon alpha, in
- Preclinical Study Explores mRNA-Based Treatment for Proliferative Vitreoretinopathyhttps://reachmd.com/news/preclinical-study-explores-mrna-based-treatment-for-proliferative-vitreoretinopathy/2470685/A preclinical study from Mass Eye and Ear offers hope for patients at risk of blindness caused by proliferative vitreoretinopathy (PVR), a severe complication of retinal detachment or eye trauma. PVR occurs when scar tissue forms inside the eye, detaching the retina and impairing vision. The nove
- Extended Analysis Confirms Favorable Safety for Upadacitinibhttps://reachmd.com/news/extended-analysis-confirms-favorable-safety-upadacitinib/2470761/Results from a long-term integrated analysis support the favorable safety profile of upadacitinib for moderate-to-severe atopic dermatitis (AD) in adolescents and adults. The analysis, presented at the recent Revolutionizing Atopic Dermatitis (RAD) Conference, included over 9,000 patient-y
- Neurologic Manifestations of Long COVID Disproportionately Affect Younger and Middle-Age Adultshttps://reachmd.com/news/neurologic-manifestations-of-long-covid-disproportionately-affect-younger-and-middle-age-adults/2470669/Younger and middle-aged adults appear to be disproportionately impacted by neurologic symptoms of long COVID, according to a study published in the Annals of Neurology. The findings reveal unique age-related differences in symptom burden, cognitive performance, and quality of life, parti
- Arcutis Submits sNDA for Roflumilast for Children 2 to 5 with ADhttps://reachmd.com/news/arcutis-submits-snda-for-roflumilast-for-children-2-to-5-with-ad/2470671/Arcutis Biotherapeutics, Inc. announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for roflumilast (ZORYVE) cream 0.05%, a once-daily, next-generation phosphodiesterase 4 (PDE4) inhibitor, for the topical treatment of mild-t
- Nasal Mycobiomes May Hold Clues to Allergic Rhinitis and Asthmahttps://reachmd.com/news/nasal-mycobiomes-may-hold-clues-to-allergic-rhinitis-and-asthma/2470756/A growing body of research highlights the intricate relationship between the nasal microbiome and respiratory diseases, such as allergic rhinitis and asthma. A new study published in Frontiers in Microbiology has uncovered distinct differences in nasal fungal communities, or mycobiomes,
- Frequent Cannabis Use Raises Psychosis Risk, Regardless of Geneticshttps://reachmd.com/news/frequent-cannabis-use-raises-psychosis-risk-regardless-of-genetics/2470680/A new study published in Psychological Medicine reveals that frequent use of cannabis, particularly high-potency varieties, raises the risk of developing psychosis regardless of an individual’s genetic predisposition for schizophrenia. The research was conducted by scientists at King’s C